METABOGENOMICS Trademark

Trademark Overview


On Monday, November 27, 2023, a trademark application was filed for METABOGENOMICS with the United States Patent and Trademark Office. The USPTO has given the METABOGENOMICS trademark a serial number of 98286230. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Sunday, July 7, 2024. This trademark is owned by Metabolon, Inc.. The METABOGENOMICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and drug development services for the purposes of biomarker discovery through the application of metabolomics; Scientific, clinical and pharmaceutical research and drug development services for the purposes of biomarker discovery through the application of metabolomics, namely, providing consultation and analysis in detection of small molecules, measuring metabolite levels, diagnosing disorders, identifying small molecule biochemical pathways and determining drug target attributes; Scientific, clinical and pharmaceutical research and drug development services for the purposes of biomarker discovery through the application of metabolomics, namely, providing consultation and analysis to provide metabolite identification and quantification including complex lipids, as well as metabolite panels and targeted assays; providing an internet website portal featuring both raw and interpreted data from metabolomics and lipidomic studies, featuring temporary use of non-downloadable softwa...
metabogenomics

General Information


Serial Number98286230
Word MarkMETABOGENOMICS
Filing DateMonday, November 27, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateSunday, July 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch and drug development services for the purposes of biomarker discovery through the application of metabolomics; Scientific, clinical and pharmaceutical research and drug development services for the purposes of biomarker discovery through the application of metabolomics, namely, providing consultation and analysis in detection of small molecules, measuring metabolite levels, diagnosing disorders, identifying small molecule biochemical pathways and determining drug target attributes; Scientific, clinical and pharmaceutical research and drug development services for the purposes of biomarker discovery through the application of metabolomics, namely, providing consultation and analysis to provide metabolite identification and quantification including complex lipids, as well as metabolite panels and targeted assays; providing an internet website portal featuring both raw and interpreted data from metabolomics and lipidomic studies, featuring temporary use of non-downloadable software for visualizing the data and for accessing knowledge-based articles, annotations, and information on known metabolites, as well as allowing users to upload raw and interpreted data; providing an on-line searchable database featuring science-related information about metabolites; Providing scientific information in the field of lipid metabolism to others that results from the organization, visualization and analysis of lipid metabolite data from an online computer database; quantitative analysis of metabolites; scientific research and laboratory research in the field of metabolic biochemistry; providing temporary use of on-line, non-downloadable software for generating visualizations of datasets; providing temporary use of online, non-downloadable software for generating visualizations of datasets in the fields of life sciences and healthcare; providing an interactive website featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 18, 2024
Primary Code042
First Use Anywhere DateWednesday, November 15, 2023
First Use In Commerce DateWednesday, November 15, 2023

Trademark Owner History


Party NameMetabolon, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Trademark Events


Event DateEvent Description
Thursday, November 30, 2023NEW APPLICATION ENTERED
Sunday, July 7, 2024NON-FINAL ACTION WRITTEN
Thursday, January 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 26, 2024ASSIGNED TO EXAMINER
Sunday, July 7, 2024NON-FINAL ACTION E-MAILED
Sunday, July 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED